6
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Misonidazole Combined with Split-Course Radiotherapy in the Treatment of Invasive Carcinoma of the Larynx and the Pharynx - A Preliminary Report of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 2

, , , , , , & show all
Pages 215-220 | Published online: 08 Jul 2009

Reference

  • Abramson N., Scruggs R. P., Cavanaugh P. J. Short-course radiation therapy in the treatment of head and neck tumors. Radiology 1976; 118: 175
  • Arcangeli G., Barocas A., Mauro F., Nervi C., Spano M., Tabocchini A. Multiple daily fractionation (MDF) radiotherapy in association with hyperthermia and/or misonidazole: Experimental and clinical results. Cancer 1980; 45: 2707
  • Arcangeli G., Mauro F., Morelli D., Nervi C. Multiple daily fractionation in radiotherapy: Biological rationale and preliminary clinical experiences. Europ I Cancer 1979; 15: 1077
  • Barkley H. T., Jr., Fletcher G. H. The significance of residual disease after external irradiation of squamous-cell carcinoma of the oropharynx. Radiology 1977; 124: 493
  • Denekamp J., McNally N. T., Fowler J. F., Joiner M. C. Misonidazole in fractionated radiotherapy: are many small fractions best?. Br J Radiol 1980; 53: 981
  • Dische S., Gray A. T., Zanelli G. D. Clinical testing of the radiosensitiser Ro-07–0582. II. Radiosensitisation of normal and hypoxic skin. Clin Radiol 1976; 27: 159
  • Dische S., Saunders M. I., Anderson P., Urtasun R. C., Karcher K. H., Kogelnik H. D., Bleehen N., Phillips T. L., Wasserman T. H. The neurotoxicity of misonidazole: pooling of data from five centres. Br J Radiol 1978; 51: 1023
  • Dische S., Saunders M. I., Flockhart I. R., Lee M. E., Anderson P. Misonidazole - a drug for trial in radiotherapy and oncology. Int J Radiat Oncol Biol Phys 1979; 5: 851
  • Henk J. M., James K. W. Comparative trial of large and small fractions in the radiotherapy of head and neck cancer. Clin Radiol 1978; 29: 611
  • Hjelm-Hansen M. Laryngeal carcinoma. IV. Analysis of treatment results using the Cohen model. Acta Radiol Oncol 1980; 19: 3
  • Kogelnik H. D. Clinical experience with misonidazole. High dose fractions versus daily low doses. Cancer Clin Trials 1980; 3: 179
  • Mantyla M., Kortekangas A. E., Valavaara R. A., Nordman E. M. Tumour regression during radiation treatment as a guide to prognosis. Br J Radiol 1979; 52: 972
  • Paterson I. C. M., Dawes P. J. D. K., Henk J. M., Moore J. L. Pilot study of radiotherapy with misonidazole in head and neck cancer. Clin Radiol 1981; 32: 225
  • Peters L. J., Withers H. R. Morbidity from large dose fractions in radiotherapy. Br J Radiol 1980; 53: 170
  • Saunders M. I., Dische S., Kogelnik H. D., Sealy R., Lenox-Smith I. Skin rashes associated with the administration of the 2-nitroimidazole, misonidazole. Cancer Treat Rep 1980; 64: 263
  • Sealy R. A preliminary clinical study in the use of misonidazole in cancer of the head and neck. Br J Cancer 1978; 37: 314, Suppl. Ill
  • Sobel S., Rubin P., Keller B., Poulter C. Tumor persistence as a predictor of outcome after radiation therapy of head and neck cancers. Int J Radiat Oncol Biol Phys 1976; 1: 873
  • Wasserman T. H., Stetz J., Phillips T. L. Radiation therapy oncology group clinical trials with misonidazole. Cancer 1981; 47: 2382
  • Withers H. R., Thames H. D., Jr., Flow B. L., Mason K. A., Hussey D. H. The relationship of acute to late skin injury in 2 and 5 fraction/week y-ray therapy. Int J Radiat Oncol Biol Phys 1978; 4: 595

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.